UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Maximize your weekends with these quick money-making ideas. Discover ways to earn extra cash without a long-term commitment.
19,179 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A high-profile insider sale at Urban Outfitters has investors weighing risk and opportunity. Learn how to interpret t...
Trust Wallet has unveiled automatic Address Poisoning Protection to shield users from spoofing attacks. The feature a...
Investors are weighing three very different tech names as AI upgrades drive Nvidia higher while Qualcomm faces a toug...
Retiring in Hawaii sounds idyllic, but the hidden downsides retiring hawaii emerge when costs, care access, and trave...
The Jets ETF has breached critical chart support, suggesting airline stocks face risks beyond rising fuel costs. Tech...
Both Salesforce and ServiceNow sit at the core of enterprise software. This guide breaks down which stock offers more...
Executives from banking, asset management, and consulting gathered at Hampton Court Palace to launch a private-sector...
Egg prices have fallen sharply over the past year, easing grocery bills as households gear up for Easter. Here's what...
Two bold paths in clean energy collide: hydrogen fuel cells from Plug Power and small modular nuclear reactors from O...
Bittensor TAO surged over the past week, with chart chatter pointing to a possible breakout even as some indicators w...
A BrightEdge analysis shows google’s overviews more likely to surface negative brand signals than ChatGPT, with broad...